Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 30 entries
Sorted by: Best Match Show Resources per page
Reply to Chu, et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Zhang B, Huaman MA, Fichtenbaum CJ, Longenecker CT.
PMID: 34181726
Clin Infect Dis. 2021 Jun 28; doi: 10.1093/cid/ciab592. Epub 2021 Jun 28.

No abstract available.

Cite
Zhang B, Huaman MA, Fichtenbaum CJ, et al. Reply to Chu, et al. Clin Infect Dis. 2021;doi: 10.1093/cid/ciab592.
Zhang, B., Huaman, M. A., Fichtenbaum, C. J., & Longenecker, C. T. (2021). Reply to Chu, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab592
Zhang, Bin, et al. "Reply to Chu, et al." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab592
Zhang B, Huaman MA, Fichtenbaum CJ, Longenecker CT. Reply to Chu, et al. Clin Infect Dis. 2021 Jun 28; doi: 10.1093/cid/ciab592. Epub 2021 Jun 28. PMID: 34181726.
Copy Download .nbib Format: NLM
Elevated Circulating Concentrations of Interferon-Gamma in Latent Tuberculosis Infection.

Pathogens & immunity

Huaman MA, Deepe GS, Fichtenbaum CJ.
PMID: 27853753
Pathog Immun. 2016 Fall-Winter;1(2):291-303. doi: 10.20411/pai.v1i2.149.

BACKGROUND: Latent tuberculosis infection (LTBI) has been associated with increased immune activation. We assessed circulating concentrations of interferon-gamma in persons with LTBI.METHODS: We used the 2011-2012 National Health Nutritional Examination Survey (NHANES) to identify adults with and without LTBI...

Cite
Huaman MA, Deepe GS, Fichtenbaum CJ. Elevated Circulating Concentrations of Interferon-Gamma in Latent Tuberculosis Infection. Pathog Immun. 2016;1(2):291-303doi: 10.20411/pai.v1i2.149.
Huaman, M. A., Deepe, G. S., & Fichtenbaum, C. J. (2016). Elevated Circulating Concentrations of Interferon-Gamma in Latent Tuberculosis Infection. Pathogens & immunity, 1(2), 291-303. https://doi.org/10.20411/pai.v1i2.149
Huaman, Moises A, et al. "Elevated Circulating Concentrations of Interferon-Gamma in Latent Tuberculosis Infection." Pathogens & immunity vol. 1,2 (2016): 291-303. doi: https://doi.org/10.20411/pai.v1i2.149
Huaman MA, Deepe GS, Fichtenbaum CJ. Elevated Circulating Concentrations of Interferon-Gamma in Latent Tuberculosis Infection. Pathog Immun. 2016 Fall-Winter;1(2):291-303. doi: 10.20411/pai.v1i2.149. PMID: 27853753; PMCID: PMC5108047.
Copy Download .nbib Format: NLM
Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus.

Open forum infectious diseases

Kileel EM, Lo J, Malvestutto C, Fitch KV, Zanni MV, Fichtenbaum CJ, Overton ET, Okeke NL, Kumar P, Joao E, Aberg JA, Martinez E, Currier JS, Douglas PS, Ribaudo HJ, Grinspoon SK.
PMID: 34888395
Open Forum Infect Dis. 2021 Nov 20;8(12):ofab537. doi: 10.1093/ofid/ofab537. eCollection 2021 Dec.

BACKGROUND: Emerging data demonstrate that the use of integrase inhibitor (INSTI)-based antiretroviral treatment (ART) is associated with increased weight, but the cardiometabolic health consequences of increased weight remains poorly understood.METHODS: This analysis examined INSTI use (>6 months) at entry...

Cite
Kileel EM, Lo J, Malvestutto C, et al. Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus. Open Forum Infect Dis. 2021;8(12):ofab537doi: 10.1093/ofid/ofab537.
Kileel, E. M., Lo, J., Malvestutto, C., Fitch, K. V., Zanni, M. V., Fichtenbaum, C. J., Overton, E. T., Okeke, N. L., Kumar, P., Joao, E., Aberg, J. A., Martinez, E., Currier, J. S., Douglas, P. S., Ribaudo, H. J., & Grinspoon, S. K. (2021). Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus. Open forum infectious diseases, 8(12), ofab537. https://doi.org/10.1093/ofid/ofab537
Kileel, Emma M, et al. "Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus." Open forum infectious diseases vol. 8,12 (2021): ofab537. doi: https://doi.org/10.1093/ofid/ofab537
Kileel EM, Lo J, Malvestutto C, Fitch KV, Zanni MV, Fichtenbaum CJ, Overton ET, Okeke NL, Kumar P, Joao E, Aberg JA, Martinez E, Currier JS, Douglas PS, Ribaudo HJ, Grinspoon SK. Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus. Open Forum Infect Dis. 2021 Nov 20;8(12):ofab537. doi: 10.1093/ofid/ofab537. eCollection 2021 Dec. PMID: 34888395; PMCID: PMC8651160.
Copy Download .nbib Format: NLM
Autoimmune Global Amnesia as Manifestation of AMPAR Encephalitis and Neuropathologic Findings.

Neurology(R) neuroimmunology & neuroinflammation

Ricken G, Zrzavy T, Macher S, Altmann P, Troger J, Falk KK, Kiefer A, Fichtenbaum A, Mitulovic G, Kubista H, Wandinger KP, Rommer P, Bartsch T, Berger T, Weber J, Leypoldt F, Höftberger R.
PMID: 34016735
Neurol Neuroimmunol Neuroinflamm. 2021 May 20;8(4). doi: 10.1212/NXI.0000000000001019. Print 2021 Jul.

OBJECTIVE: To report an unusual clinical phenotype of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis and describe associated neuropathologic findings.METHODS: We retrospectively investigated 3 AMPAR encephalitis patients with autoimmune global hippocampal amnesia using comprehensive cognitive and neuropsychologic assessment, antibody testing by...

Cite
Ricken G, Zrzavy T, Macher S, et al. Autoimmune Global Amnesia as Manifestation of AMPAR Encephalitis and Neuropathologic Findings. Neurol Neuroimmunol Neuroinflamm. 2021;8(4)doi: 10.1212/NXI.0000000000001019.
Ricken, G., Zrzavy, T., Macher, S., Altmann, P., Troger, J., Falk, K. K., Kiefer, A., Fichtenbaum, A., Mitulovic, G., Kubista, H., Wandinger, K. P., Rommer, P., Bartsch, T., Berger, T., Weber, J., Leypoldt, F., & Höftberger, R. (2021). Autoimmune Global Amnesia as Manifestation of AMPAR Encephalitis and Neuropathologic Findings. Neurology(R) neuroimmunology & neuroinflammation, 8(4), . https://doi.org/10.1212/NXI.0000000000001019
Ricken, Gerda, et al. "Autoimmune Global Amnesia as Manifestation of AMPAR Encephalitis and Neuropathologic Findings." Neurology(R) neuroimmunology & neuroinflammation vol. 8,4 (2021). doi: https://doi.org/10.1212/NXI.0000000000001019
Ricken G, Zrzavy T, Macher S, Altmann P, Troger J, Falk KK, Kiefer A, Fichtenbaum A, Mitulovic G, Kubista H, Wandinger KP, Rommer P, Bartsch T, Berger T, Weber J, Leypoldt F, Höftberger R. Autoimmune Global Amnesia as Manifestation of AMPAR Encephalitis and Neuropathologic Findings. Neurol Neuroimmunol Neuroinflamm. 2021 May 20;8(4). doi: 10.1212/NXI.0000000000001019. Print 2021 Jul. PMID: 34016735; PMCID: PMC8142837.
Copy Download .nbib Format: NLM
A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy.

Open forum infectious diseases

Presti RM, Yeh E, Williams B, Landay A, Jacobson JM, Wilson C, Fichtenbaum CJ, Utay NS, Dube MP, Klingman KL, Estes JD, Flynn JK, Loftin A, Brenchley JM, Andrade A, Kitch DW, Overton ET.
PMID: 34888397
Open Forum Infect Dis. 2021 Dec 07;8(12):ofab550. doi: 10.1093/ofid/ofab550. eCollection 2021 Dec.

BACKGROUND: A5350, a phase II, randomized, double-blind study, evaluated the safety and tolerability of the probiotic Visbiome Extra Strength (ES) over 24 weeks and measured effects on inflammation and intestinal barrier function.METHODS: The primary outcome was change in soluble...

Cite
Presti RM, Yeh E, Williams B, et al. A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy. Open Forum Infect Dis. 2021;8(12):ofab550doi: 10.1093/ofid/ofab550.
Presti, R. M., Yeh, E., Williams, B., Landay, A., Jacobson, J. M., Wilson, C., Fichtenbaum, C. J., Utay, N. S., Dube, M. P., Klingman, K. L., Estes, J. D., Flynn, J. K., Loftin, A., Brenchley, J. M., Andrade, A., Kitch, D. W., & Overton, E. T. (2021). A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy. Open forum infectious diseases, 8(12), ofab550. https://doi.org/10.1093/ofid/ofab550
Presti, Rachel M, et al. "A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy." Open forum infectious diseases vol. 8,12 (2021): ofab550. doi: https://doi.org/10.1093/ofid/ofab550
Presti RM, Yeh E, Williams B, Landay A, Jacobson JM, Wilson C, Fichtenbaum CJ, Utay NS, Dube MP, Klingman KL, Estes JD, Flynn JK, Loftin A, Brenchley JM, Andrade A, Kitch DW, Overton ET. A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy. Open Forum Infect Dis. 2021 Dec 07;8(12):ofab550. doi: 10.1093/ofid/ofab550. eCollection 2021 Dec. PMID: 34888397; PMCID: PMC8651169.
Copy Download .nbib Format: NLM
A Randomized Study of the Impact of a Corneal Pre-Cut During Cataract Surgery on Wound Architecture and Corneal Astigmatism.

Ophthalmology and therapy

Doeller B, Hirnschall N, Fichtenbaum M, Nguyen PM, Varsits R, Findl O.
PMID: 33709325
Ophthalmol Ther. 2021 Jun;10(2):313-320. doi: 10.1007/s40123-021-00339-0. Epub 2021 Mar 11.

INTRODUCTION: The aim of the current study was to assess the effect of a 600-µm corneal pre-cut on wound architecture and its impact on surgically induced astigmatism. The images were acquired intraoperatively and postoperatively with high-resolution spectral-domain optical coherence...

Cite
Doeller B, Hirnschall N, Fichtenbaum M, et al. A Randomized Study of the Impact of a Corneal Pre-Cut During Cataract Surgery on Wound Architecture and Corneal Astigmatism. Ophthalmol Ther. 2021;10(2):313-320doi: 10.1007/s40123-021-00339-0.
Doeller, B., Hirnschall, N., Fichtenbaum, M., Nguyen, P. M., Varsits, R., & Findl, O. (2021). A Randomized Study of the Impact of a Corneal Pre-Cut During Cataract Surgery on Wound Architecture and Corneal Astigmatism. Ophthalmology and therapy, 10(2), 313-320. https://doi.org/10.1007/s40123-021-00339-0
Doeller, Birgit, et al. "A Randomized Study of the Impact of a Corneal Pre-Cut During Cataract Surgery on Wound Architecture and Corneal Astigmatism." Ophthalmology and therapy vol. 10,2 (2021): 313-320. doi: https://doi.org/10.1007/s40123-021-00339-0
Doeller B, Hirnschall N, Fichtenbaum M, Nguyen PM, Varsits R, Findl O. A Randomized Study of the Impact of a Corneal Pre-Cut During Cataract Surgery on Wound Architecture and Corneal Astigmatism. Ophthalmol Ther. 2021 Jun;10(2):313-320. doi: 10.1007/s40123-021-00339-0. Epub 2021 Mar 11. PMID: 33709325; PMCID: PMC8079538.
Copy Download .nbib Format: NLM
Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy.

Journal of clinical lipidology

Stein JH, Komarow L, Cotter BR, Currier JS, Dubé MP, Fichtenbaum CJ, Gerschenson M, Mitchell CK, Murphy RL, Squires K, Parker RA, Torriani FJ.
PMID: 19956354
J Clin Lipidol. 2008 Dec;2(6):464-471. doi: 10.1016/j.jacl.2008.08.442.

BACKGROUND: Dyslipidemia is a frequent complication of antiretroviral therapy (ART) for patients with human immunodeficiency virus infection (HIV). The effects of ART on lipoproteins are less well-understood, and have not been investigated in a prospective study where assignment to...

Cite
Stein JH, Komarow L, Cotter BR, et al. Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy. J Clin Lipidol. 2008;2(6):464-471doi: 10.1016/j.jacl.2008.08.442.
Stein, J. H., Komarow, L., Cotter, B. R., Currier, J. S., Dubé, M. P., Fichtenbaum, C. J., Gerschenson, M., Mitchell, C. K., Murphy, R. L., Squires, K., Parker, R. A., Torriani, F. J. (2008). Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy. Journal of clinical lipidology, 2(6), 464-471. https://doi.org/10.1016/j.jacl.2008.08.442
Stein, James H, et al. "Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy." Journal of clinical lipidology vol. 2,6 (2008): 464-471. doi: https://doi.org/10.1016/j.jacl.2008.08.442
Stein JH, Komarow L, Cotter BR, Currier JS, Dubé MP, Fichtenbaum CJ, Gerschenson M, Mitchell CK, Murphy RL, Squires K, Parker RA, Torriani FJ. Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy. J Clin Lipidol. 2008 Dec;2(6):464-471. doi: 10.1016/j.jacl.2008.08.442. PMID: 19956354; PMCID: PMC2636959.
Copy Download .nbib Format: NLM
Inflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection.

Current infectious disease reports

Fichtenbaum CJ.
PMID: 21308460
Curr Infect Dis Rep. 2011 Feb;13(1):94-101. doi: 10.1007/s11908-010-0153-9.

Coronary heart disease (CHD) is an inflammatory process that takes decades to develop. In HIV-seronegative persons, high-sensitivity C-reactive protein is a biologic marker of CHD risk. HIV infection induces chronic inflammation, despite adequate suppression of HIV replication with antiretroviral...

Cite
Fichtenbaum CJ. Inflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection. Curr Infect Dis Rep. 2011;13(1):94-101doi: 10.1007/s11908-010-0153-9.
Fichtenbaum, C. J. (2011). Inflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection. Current infectious disease reports, 13(1), 94-101. https://doi.org/10.1007/s11908-010-0153-9
Fichtenbaum, Carl J. "Inflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection." Current infectious disease reports vol. 13,1 (2011): 94-101. doi: https://doi.org/10.1007/s11908-010-0153-9
Fichtenbaum CJ. Inflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection. Curr Infect Dis Rep. 2011 Feb;13(1):94-101. doi: 10.1007/s11908-010-0153-9. PMID: 21308460; PMCID: PMC3077066.
Copy Download .nbib Format: NLM
Entrustment and mapping of observable practice activities for resident assessment.

Journal of general internal medicine

Warm EJ, Mathis BR, Held JD, Pai S, Tolentino J, Ashbrook L, Lee CK, Lee D, Wood S, Fichtenbaum CJ, Schauer D, Munyon R, Mueller C.
PMID: 24557518
J Gen Intern Med. 2014 Aug;29(8):1177-82. doi: 10.1007/s11606-014-2801-5. Epub 2014 Feb 21.

Entrustable Professional Activities (EPAs) and the Next Accreditation System reporting milestones reduce general competencies into smaller evaluable parts. However, some EPAs and reporting milestones may be too broad to use as direct assessment tools. We describe our internal medicine...

Cite
Warm EJ, Mathis BR, Held JD, et al. Entrustment and mapping of observable practice activities for resident assessment. J Gen Intern Med. 2014;29(8):1177-82doi: 10.1007/s11606-014-2801-5.
Warm, E. J., Mathis, B. R., Held, J. D., Pai, S., Tolentino, J., Ashbrook, L., Lee, C. K., Lee, D., Wood, S., Fichtenbaum, C. J., Schauer, D., Munyon, R., & Mueller, C. (2014). Entrustment and mapping of observable practice activities for resident assessment. Journal of general internal medicine, 29(8), 1177-82. https://doi.org/10.1007/s11606-014-2801-5
Warm, Eric J, et al. "Entrustment and mapping of observable practice activities for resident assessment." Journal of general internal medicine vol. 29,8 (2014): 1177-82. doi: https://doi.org/10.1007/s11606-014-2801-5
Warm EJ, Mathis BR, Held JD, Pai S, Tolentino J, Ashbrook L, Lee CK, Lee D, Wood S, Fichtenbaum CJ, Schauer D, Munyon R, Mueller C. Entrustment and mapping of observable practice activities for resident assessment. J Gen Intern Med. 2014 Aug;29(8):1177-82. doi: 10.1007/s11606-014-2801-5. Epub 2014 Feb 21. PMID: 24557518; PMCID: PMC4099463.
Copy Download .nbib Format: NLM
Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention.

JAMA network open

Hoffmann U, Lu MT, Foldyna B, Zanni MV, Karady J, Taron J, Zhai BK, Burdo T, Fitch KV, Kileel EM, Williams K, Fichtenbaum CJ, Overton ET, Malvestutto C, Aberg J, Currier J, Sponseller CA, Melbourne K, Floris-Moore M, Van Dam C, Keefer MC, Koletar SL, Douglas PS, Ribaudo H, Mayrhofer T, Grinspoon SK.
PMID: 34185068
JAMA Netw Open. 2021 Jun 01;4(6):e2114923. doi: 10.1001/jamanetworkopen.2021.14923.

IMPORTANCE: Cardiovascular disease (CVD) is increased among people with HIV (PWH), but little is known regarding the prevalence and extent of coronary artery disease (CAD) and associated biological factors in PWH with low to moderate traditional CVD risk.OBJECTIVES: To...

Cite
Hoffmann U, Lu MT, Foldyna B, et al. Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention. JAMA Netw Open. 2021;4(6):e2114923doi: 10.1001/jamanetworkopen.2021.14923.
Hoffmann, U., Lu, M. T., Foldyna, B., Zanni, M. V., Karady, J., Taron, J., Zhai, B. K., Burdo, T., Fitch, K. V., Kileel, E. M., Williams, K., Fichtenbaum, C. J., Overton, E. T., Malvestutto, C., Aberg, J., Currier, J., Sponseller, C. A., Melbourne, K., Floris-Moore, M., Van Dam, C., Keefer, M. C., Koletar, S. L., Douglas, P. S., Ribaudo, H., Mayrhofer, T., Grinspoon, S. K. (2021). Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention. JAMA network open, 4(6), e2114923. https://doi.org/10.1001/jamanetworkopen.2021.14923
Hoffmann, Udo, et al. "Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention." JAMA network open vol. 4,6 (2021): e2114923. doi: https://doi.org/10.1001/jamanetworkopen.2021.14923
Hoffmann U, Lu MT, Foldyna B, Zanni MV, Karady J, Taron J, Zhai BK, Burdo T, Fitch KV, Kileel EM, Williams K, Fichtenbaum CJ, Overton ET, Malvestutto C, Aberg J, Currier J, Sponseller CA, Melbourne K, Floris-Moore M, Van Dam C, Keefer MC, Koletar SL, Douglas PS, Ribaudo H, Mayrhofer T, Grinspoon SK. Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention. JAMA Netw Open. 2021 Jun 01;4(6):e2114923. doi: 10.1001/jamanetworkopen.2021.14923. PMID: 34185068; PMCID: PMC8243232.
Copy Download .nbib Format: NLM
Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.

The Journal of infectious diseases

Fichtenbaum CJ, Ribaudo HJ, Leon-Cruz J, Overton ET, Zanni MV, Malvestutto CD, Aberg JA, Kileel EM, Fitch KV, Van Schalkwyk M, Kumarasamy N, Martinez E, Santos BR, Joseph Y, Lo J, Siminski S, Melbourne K, Sponseller CA, Desvigne-Nickens P, Bloomfield GS, Currier JS, Hoffmann U, Douglas PS, Grinspoon SK.
PMID: 33068427
J Infect Dis. 2021 Feb 03;223(2):352. doi: 10.1093/infdis/jiaa594.

No abstract available.

Cite
Fichtenbaum CJ, Ribaudo HJ, Leon-Cruz J, et al. Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. J Infect Dis. 2021;223(2):352doi: 10.1093/infdis/jiaa594.
Fichtenbaum, C. J., Ribaudo, H. J., Leon-Cruz, J., Overton, E. T., Zanni, M. V., Malvestutto, C. D., Aberg, J. A., Kileel, E. M., Fitch, K. V., Van Schalkwyk, M., Kumarasamy, N., Martinez, E., Santos, B. R., Joseph, Y., Lo, J., Siminski, S., Melbourne, K., Sponseller, C. A., Desvigne-Nickens, P., Bloomfield, G. S., Currier, J. S., Hoffmann, U., Douglas, P. S., & Grinspoon, S. K. (2021). Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. The Journal of infectious diseases, 223(2), 352. https://doi.org/10.1093/infdis/jiaa594
Fichtenbaum, Carl J, et al. "Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial." The Journal of infectious diseases vol. 223,2 (2021): 352. doi: https://doi.org/10.1093/infdis/jiaa594
Fichtenbaum CJ, Ribaudo HJ, Leon-Cruz J, Overton ET, Zanni MV, Malvestutto CD, Aberg JA, Kileel EM, Fitch KV, Van Schalkwyk M, Kumarasamy N, Martinez E, Santos BR, Joseph Y, Lo J, Siminski S, Melbourne K, Sponseller CA, Desvigne-Nickens P, Bloomfield GS, Currier JS, Hoffmann U, Douglas PS, Grinspoon SK. Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. J Infect Dis. 2021 Feb 03;223(2):352. doi: 10.1093/infdis/jiaa594. PMID: 33068427; PMCID: PMC8112120.
Copy Download .nbib Format: NLM
Serum Bovine Immunoglobulins Improve Inflammation and Gut Barrier Function in Persons with HIV and Enteropathy on Suppressive ART.

Pathogens & immunity

Utay NS, Somasunderam A, Hinkle JE, Petschow BW, Detzel CJ, Somsouk M, Fichtenbaum CJ, Weaver EM, Shaw AL, Asmuth DM.
PMID: 31139758
Pathog Immun. 2019 May 03;4(1):124-146. doi: 10.20411/pai.v4i1.276. eCollection 2019.

BACKGROUND: Systemic inflammation persists in chronic HIV infection and is associated with increased rates of non-AIDS events such as cardiovascular and liver disease. Increased gut permeability and systemic exposure to microbial products are key drivers of this inflammation. Serum-derived...

Cite
Utay NS, Somasunderam A, Hinkle JE, et al. Serum Bovine Immunoglobulins Improve Inflammation and Gut Barrier Function in Persons with HIV and Enteropathy on Suppressive ART. Pathog Immun. 2019;4(1):124-146doi: 10.20411/pai.v4i1.276.
Utay, N. S., Somasunderam, A., Hinkle, J. E., Petschow, B. W., Detzel, C. J., Somsouk, M., Fichtenbaum, C. J., Weaver, E. M., Shaw, A. L., & Asmuth, D. M. (2019). Serum Bovine Immunoglobulins Improve Inflammation and Gut Barrier Function in Persons with HIV and Enteropathy on Suppressive ART. Pathogens & immunity, 4(1), 124-146. https://doi.org/10.20411/pai.v4i1.276
Utay, Netanya S, et al. "Serum Bovine Immunoglobulins Improve Inflammation and Gut Barrier Function in Persons with HIV and Enteropathy on Suppressive ART." Pathogens & immunity vol. 4,1 (2019): 124-146. doi: https://doi.org/10.20411/pai.v4i1.276
Utay NS, Somasunderam A, Hinkle JE, Petschow BW, Detzel CJ, Somsouk M, Fichtenbaum CJ, Weaver EM, Shaw AL, Asmuth DM. Serum Bovine Immunoglobulins Improve Inflammation and Gut Barrier Function in Persons with HIV and Enteropathy on Suppressive ART. Pathog Immun. 2019 May 03;4(1):124-146. doi: 10.20411/pai.v4i1.276. eCollection 2019. PMID: 31139758; PMCID: PMC6508431.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 30 entries